QQ客服 官方微博 反馈留言

	Combination of Atorvastatin and Atorvastatin-pretreated Mesenchymal Stem Cells Improves the Cardiac Performance after Acute Myocardial Infarction by Targeting SDF-1/CXCR4 axis
	Tian, Xiaqiu; Yang, Yuejin
	2018
卷号	72期号:16页码:C69-C69
ISSN号	0735-1097
DOI	10.1016/j.jacc.2018.08.401
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6353260
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Tian, Xiaqiu,Yang, Yuejin. Combination of Atorvastatin and Atorvastatin-pretreated Mesenchymal Stem Cells Improves the Cardiac Performance after Acute Myocardial Infarction by Targeting SDF-1/CXCR4 axis[J],2018,72(16):C69-C69.
APA	Tian, Xiaqiu,&Yang, Yuejin.(2018).Combination of Atorvastatin and Atorvastatin-pretreated Mesenchymal Stem Cells Improves the Cardiac Performance after Acute Myocardial Infarction by Targeting SDF-1/CXCR4 axis.,72(16),C69-C69.
MLA	Tian, Xiaqiu,et al."Combination of Atorvastatin and Atorvastatin-pretreated Mesenchymal Stem Cells Improves the Cardiac Performance after Acute Myocardial Infarction by Targeting SDF-1/CXCR4 axis".72.16(2018):C69-C69.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。